Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

ZTS | Zoetis Inc

IndexS&P 500 P/E37.39 EPS (ttm)4.75 Insider Own0.07% Shs Outstand501.89M Perf Week-1.07%
Market Cap81.81B Forward P/E29.21 EPS next Y6.09 Insider Trans-11.84% Shs Float459.98M Perf Month-2.11%
Income2.21B PEG3.26 EPS next Q1.38 Inst Own92.59% Short Float / Ratio0.80% / 2.06 Perf Quarter6.08%
Sales8.22B P/S9.95 EPS this Y11.50% Inst Trans0.02% Short Interest3.69M Perf Half Y8.25%
Book/sh10.04 P/B17.70 EPS next Y11.84% ROA16.08% Target Price223.00 Perf Year18.91%
Cash/sh3.73 P/C47.65 EPS next 5Y11.48% ROE48.08% 52W Range124.15 - 194.99 Perf YTD21.27%
Dividend1.51 P/FCF63.66 EPS past 5Y20.76% ROI19.47% 52W High-8.86% Beta0.79
Dividend %0.85% Quick Ratio1.97 Sales past 5Y8.85% Gross Margin68.37% 52W Low43.15% ATR3.73
Employees13800 Current Ratio3.50 Sales Q/Q6.24% Oper. Margin36.18% RSI (14)39.93 Volatility1.89% 1.92%
OptionableYes Debt/Eq1.46 EPS Q/Q29.20% Profit Margin26.92% Rel Volume0.86 Prev Close176.68
ShortableYes LT Debt/Eq1.46 EarningsAug 08 BMO Payout30.04% Avg Volume1.79M Price177.72
Recom1.33 SMA20-4.05% SMA50-3.44% SMA2004.20% Volume1,551,129 Change0.59%
Date Action Analyst Rating Change Price Target Change
Sep-06-23Initiated HSBC Securities Buy $230
Jul-12-22Initiated Piper Sandler Overweight $205
Nov-18-21Initiated Morgan Stanley Overweight $40
Nov-18-21Initiated Morgan Stanley Overweight $264
Aug-05-21Resumed Credit Suisse Outperform $206
Jul-16-21Downgrade Raymond James Outperform → Mkt Perform
Mar-08-21Upgrade Raymond James Mkt Perform → Outperform $166
Mar-08-21Upgrade BofA Securities Neutral → Buy $180
Sep-21-20Initiated Atlantic Equities Overweight $191
Aug-14-20Upgrade Edward Jones Hold → Buy
Sep-24-23 07:10PM
Sep-20-23 03:00AM
Sep-19-23 01:31PM
Sep-15-23 06:29PM
Sep-13-23 11:40AM
09:55AM Loading…
09:55AM
Sep-12-23 05:11PM
06:40AM
Sep-09-23 07:01AM
Sep-07-23 11:30AM
07:45AM
07:00AM
Sep-06-23 04:30PM
Aug-31-23 10:53PM
Aug-30-23 02:07PM
06:24PM Loading…
Aug-29-23 06:24PM
Aug-28-23 12:08PM
11:40AM
Aug-25-23 08:44AM
Aug-24-23 02:32PM
Aug-23-23 11:40AM
09:26AM
Aug-22-23 12:37PM
Aug-17-23 03:00PM
Aug-11-23 12:18PM
12:18PM
Aug-10-23 11:40AM
Aug-09-23 06:33PM
02:18PM
11:40AM
11:17PM Loading…
Aug-08-23 11:17PM
04:09PM
02:30PM
01:58PM
12:37PM
10:48AM
10:30AM
09:20AM
09:16AM
08:15AM
07:16AM
07:00AM
Aug-04-23 01:17PM
Aug-03-23 07:15AM
Aug-01-23 07:57AM
Jul-29-23 09:30AM
Jul-27-23 05:00AM
Jul-26-23 02:17PM
01:39PM
08:30AM
Jul-25-23 04:33PM
03:31PM
03:18PM
Jul-24-23 03:48AM
Jul-23-23 07:31PM
08:00AM
Jul-19-23 05:27AM
Jul-17-23 07:42AM
07:42AM
Jul-16-23 10:00AM
Jul-12-23 08:00AM
08:00AM
Jul-11-23 11:40AM
Jul-10-23 08:00AM
Jul-06-23 07:00AM
Jul-05-23 09:55AM
Jun-30-23 08:30AM
Jun-29-23 09:27AM
Jun-28-23 09:35AM
08:30AM
06:49AM
Jun-27-23 12:50PM
Jun-22-23 04:47PM
Jun-21-23 09:15AM
02:01AM
Jun-18-23 08:00AM
Jun-16-23 06:15PM
06:46AM
Jun-15-23 08:00AM
Jun-13-23 07:00AM
Jun-09-23 06:15PM
09:00AM
Jun-04-23 10:00AM
May-30-23 04:30PM
May-25-23 07:30AM
May-18-23 05:19AM
May-15-23 09:24AM
May-12-23 02:10PM
May-11-23 04:05PM
08:58AM
May-09-23 10:22AM
May-05-23 03:44PM
May-04-23 11:16PM
04:06PM
02:59PM
12:30PM
12:04PM
11:17AM
09:30AM
09:27AM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagano RoxanneExecutive Vice PresidentSep 18Sale179.58923165,75224,511Sep 18 04:25 PM
Chen Heidi C.Executive Vice PresidentSep 15Sale180.159,9051,784,38627,478Sep 18 04:15 PM
Lagano RoxanneExecutive Vice PresidentSep 01Sale192.97923178,11125,434Sep 05 05:04 PM
PECK KRISTIN CChief Executive OfficerAug 22Option Exercise45.3513,000589,58569,843Aug 22 04:21 PM
PECK KRISTIN CChief Executive OfficerAug 22Sale179.9713,0002,339,56456,843Aug 22 04:21 PM
Polzer Robert JExecutive Vice PresidentAug 09Option Exercise144.031,179169,8113,532Aug 11 04:32 PM
Polzer Robert JExecutive Vice PresidentAug 09Sale189.941,179223,9392,353Aug 11 04:32 PM
PECK KRISTIN CChief Executive OfficerMay 23Option Exercise41.8313,000543,79069,843May 25 04:13 PM
PECK KRISTIN CChief Executive OfficerMay 23Sale176.5613,0002,295,33556,843May 25 04:13 PM
Lagano RoxanneExecutive Vice PresidentApr 18Option Exercise79.854,338346,39830,695Apr 19 04:18 PM
Lagano RoxanneExecutive Vice PresidentApr 18Sale175.944,338763,22826,357Apr 19 04:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 14Option Exercise79.8513,0101,038,84339,367Feb 16 04:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 14Sale175.0013,0102,276,75026,357Feb 16 04:18 PM